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Abstract
Background
Validation of voltage-based scar delineation has been limited to small populations using
mainly endocardial measurements. The aim of this study is to compare unipolar voltage
amplitudes (UnipV) with scar on delayed enhancement cardiac magnetic resonance imag-
ing (DE-CMR).
Methods
Heart failure patients who underwent DE-CMR and electro-anatomic mapping were
included. Thirty-three endocardial mapped patients and 27 epicardial mapped patients were
investigated. UnipV were computed peak-to-peak. Electrograms were matched with scar
extent of the corresponding DE-CMR segment using a 16-segment/slice model. Non-scar
was defined as 0% scar, while scar was defined as 1–100% scar extent.
Results
UnipVs were moderately lower in scar than in non-scar (endocardial 7.1 [4.6–10.6] vs. 10.3
[7.4–14.2] mV; epicardial 6.7 [3.6–10.5] vs. 7.8 [4.2–12.3] mV; both p<0.001). The correla-
tion between UnipV and scar extent was moderate for endocardial (R = -0.33, p<0.001), and
poor for epicardial measurements (R = -0.07, p<0.001). Endocardial UnipV predicted seg-
ments with >25%, >50% and >75% scar extent with AUCs of 0.72, 0.73 and 0.76, respec-
tively, while epicardial UnipV were poor scar predictors, independent of scar burden (AUC =
0.47–0.56). UnipV in non-scar varied widely between patients (p<0.001) and were lower in
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scar compared to non-scar in only 9/22 (41%) endocardial mapped patients and 4/19 (21%)
epicardial mapped patients with scar.
Conclusion
UnipV are slightly lower in scar compared to non-scar. However, significant UnipV differ-
ences between and within patients and large overlap between non-scar and scar limits the
reliability of accurate scar assessment, especially in epicardial measurements and in seg-
ments with less than 75% scar extent.
Introduction
The measurement of voltage amplitudes to distinguish scar tissue from viable myocardium is
widely employed in invasive cardiology and electrophysiology including ablation therapy, tar-
geted delivery of biological therapy, and cardiac resynchronization therapy (CRT).[1–5] Low
voltage amplitudes are considered to be associated with scar, while high voltage amplitudes are
regarded as viable myocardium.[2]
Delayed enhancement cardiac magnetic resonance (DE-CMR) is currently the gold stan-
dard for myocardial scar delineation. Several studies have correlated low voltage amplitudes
and DE-CMR defined scar, from which most have been conducted in porcine models with
modestly reduced left ventricular (LV) ejection and a well-demarcated scar zone.[2, 6–8] How-
ever, characteristics of these models do not represent the scar heterogeneity noticed in heart
failure (HF) patients, limiting the generalizability of the results. Additionally, validation studies
of voltage-based scar delineation conducted in ventricular tachycardia (VT) or HF patients
have been limited by the small numbers of patients investigated, was particularly focused on
endocardial measurements, and do not provide data on the effectiveness at the individual
level.[3, 9, 10]
The aim of the present study was to compare voltage amplitude measurements with scar on
DE-CMR in ischemic and non-ischemic HF patients. In order to increase the generalizability
of the study results, this investigation was performed in a cohort with endocardial measure-
ments and a cohort with epicardial measurements. To this purpose, we (1) compared voltage
amplitudes with the presence of DE-CMR defined scar, (2) correlated voltage amplitudes with
segmental scar extent, and (3) evaluated the diagnostic accuracy of voltage amplitudes in
detecting scar.
Methods
Study population
HF patients (New York Heart Association class, NYHAI) who underwent DE-CMR and
epicardial (coronary venous) electro-anatomic mapping at Maastricht University Medical
Center or endocardial electro-anatomic mapping (EAM) at Cardiocentro Ticino for biological
therapy or CRT were retrospectively included. The workflow of the study is illustrated in Fig 1.
The institutional review board from Maastricht University Medical Center and the Ethics
Committee of Canton Ticino approved the study protocol and waived the need for informed
consent.
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Cardiac magnetic resonance imaging
All CMR scans were part of standard care. Acquisition protocols and post-processing data
have been extensively described previously.[11–13] In brief, CMR images were acquired with a
3-Tesla scanner (Siemens Magnetom Skyra, Germany) in CCT or a 1.5–3.0-Tesla scanner
(Philips Intera/Ingenia/Achieva, Best, the Netherlands) in MUMC. ECG-gated cine images
were obtained to determine LV functions. DE-CMR images were acquired with a phase sensi-
tive inversion recovery sequence for CCT (typical voxel size 1.2×1.2×8 mm) and a 2D inver-
sion gradient echo sequence for MUMC (typical voxel size 0.6x0.6x0.8 mm) 7–15 minutes
after an intravenous bolus (0.2 mmol/kg for CCT and 0.15 mmol/kg for MUMC) of Gadobu-
trol (Gadovist Bayer Schering Pharma, Zurich, Switzerland). Endocardium and epicardium
were manually traced from short-axis DE-CMR images using software programmed in
MATLAB R2015b (MathWorks, Natick, MA) for CCT and CAAS MRV 3.4 (Pie Medical
Imaging, Maastricht) for MUMC. Scar was semi-automatically quantified with the full-width-
half-maximum criterion. All segmentations were performed by an investigator supervised by
an experienced institutional CMR reader with over 10 years of experience (EACVI level3).
Fig 1. Study workflow. DE-CMR = delayed enhancement cardiac magnetic resonance imaging,
EAM = electro-anatomic mapping, HF = heart failure.
https://doi.org/10.1371/journal.pone.0180637.g001
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Each DE-CMR short-axis slice was subdivided in 16-segments for which the scar extent was
computed as the quantified scar area divided by the total segmental area. Non-scar was defined
as 0% scar extent, while “any-scar” was defined as 1–100% scar extent. Any-scar was further
subdivided in groups according to 1–25%, 26–50%, 51–75%, and 76–100% scar extent.
Endocardial electro-anatomic mapping and DE-CMR integration
Endocardial EAM was performed using the NOGA 1 XP Cardiac Navigation System (Bio-
sense Webster, Johnson & Johnson Company) in CCT as previously described.[11] In brief,
unipolar electrograms and catheter tip trajectories in 3D space were simultaneously recorded
at the entire LV endocardium (filter settings, bandpass: 1–240 Hz). The NOGA 1 XP system
automatically discards points with insufficient wall contact.
All the acquired signals were temporally aligned using the simultaneously recorded surface
ECG. Endocardial EAMs were integrated with DE-CMR offline by a rigid registration algo-
rithm using a two-step algorithm developed in MATLAB. First, the cloud of NOGA points
was translated to make their center of gravity overlapping with the center of gravity of the
endocardial cavity segmented from the cine CMR images at end-diastole. Second, an iterative
closest point approach was used to minimize the Euclidean distance between the NOGA
points and the endocardial contours from DE-CMR.
Epicardial electro-anatomic mapping and DE-CMR integration
Epicardial electrograms were derived from coronary venous EAMs in the MUMC, using
EnSite NavX as described previously.[12] Briefly, a guidewire permitting unipolar sensing and
pacing was inserted into the coronary sinus and manipulated to all tributaries, creating an ana-
tomic 3D map of the coronary veins while simultaneously recording electrograms (filter set-
tings, bandpass: 2–300 Hz) and a surface ECG during intrinsic rhythm. Electrograms with
poor signal indicating poor contact were manually discarded during the procedure. Epicardial
EAMs were integrated with DE-CMR using EnSite NavX by setting anatomical landmarks at
both the EAM and DE-CMR geometry. The EAM coordinate system was subsequently super-
imposed and adjusted to the DE-CMR geometry using a dynamic registration algorithm,
allowing local refinement while leaving other areas unaffected.
Electrogram analyses
Endocardial and epicardial peak-to-peak unipolar voltage amplitudes (UnipV) were automati-
cally computed using custom software programmed in MATLAB. Electrogram locations were
matched with scar extent of the corresponding DE-CMR segment.
Statistical analysis
Statistical analyses for the baseline characteristics were performed using SPSS 24.0 software
(SPSS inc. Chicago, Illinois). Continuous variables are expressed as mean±SD or median with
IQR and categorical variables in total numbers and frequencies. Two-tailed analyses were used
and a p<0.05 was considered significant. The correlation between UnipV and DE-CMR scar
extent was evaluated by partial correlation analysis controlled for inter-patient differences.
UnipV from different scar groups were compared with non-scar using ANOVA tests with
post-hoc Bonferroni correction. UnipV of any-scar vs. non-scar was compared using linear
mixed models with patients as random effect and DE-CMR scar as fixed effect. Any-scar was
compared with non-scar in individual patients using Mann-Whitney U tests. Kruskal Wallis
tests were used to compare UnipV from non-scar and any-scar between individual patients.
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ROC curves were generated to determine the diagnostic accuracy of UnipV amplitudes in
detecting segments with any-scar (1–100%) and segments with several severities of scar:
>25%, >50%, and>75% scar.
Results
Study characteristics
A total of 60 HF patients were investigated: a cohort of 33 patients underwent extensive endo-
cardial mapping (Group 1), and another cohort of 27 patients underwent epicardial mapping
(Group 2). None of the patients had mapping at both endocardial or epicardial site. Clinical
characteristics were typical of patients selected for CRT or biological therapy. Patients’ baseline
characteristics are summarized in Table 1.
Electro-anatomic mapping and DE-CMR image integration
A mean of 200±56 endocardial mapping points per patient were acquired in Group 1 for a
total of 6612 endocardial electrograms, whereas a mean of 69±26 epicardial mapping points
were acquired in Group 2 for a total of 1871 epicardial electrograms. EAMs were integrated
with DE-CMR with a Euclidean distance of 6.9±4.8 mm for endocardial and 4.7±1.1 mm for
epicardial measurements.[12] After excluding electrograms from the base, LV outflow tract,
and right ventricle, 6543 endocardial electrograms were analyzed from non-scar (n = 3002)
and any-scar (n = 3541) and 1330 epicardial electrograms from non-scar (n = 778) and any-
scar (n = 552).
Voltage amplitudes in scar vs. non-scar
Endocardial and epicardial UnipV were slightly lower in segments with any-scar compared to
non-scar (Table 2). However, variation in each category was large and box-plots in Fig 2A
illustrate high overlap between UnipV within both non-scar and any-scar. The overlap was
larger for epicardial than endocardial measurements, and particularly present in segments
with<75% scar. Median UnipV gradually decreased with increasing scar extent for endocar-
dial UnipV, but not for epicardial UnipV.
When comparing non-scar UnipV distributions (blue boxplots in Fig 3) between individual
patients, large variations in endocardial (median range: 5.1–15.4 mV, p<0.001) and epicardial
(median range: 3.6–19.4 mV, p<0.001) UnipV between patients were observed, indicating that
non-scar UnipV varied greatly between individuals. As demonstrated in Fig 3, UnipV in any-
scar (red boxplots) were only significantly lower than non-scar (blue boxplots) in 9/22 (41%)
endocardial mapped patients and 4/19 (21%) epicardial mapped patients.
Correlation of voltage amplitudes with scar extent
The correlation between UnipV and DE-CMR scar extent was moderate for endocardial (R =
-0.33, p<0.001) and weak for epicardial measurements (R = -0.07, p<0.001). Examples of the
lack of correlation between UnipV and scar in patients are represented in Figs 4 and 5.
Diagnostic accuracy of voltage amplitudes in scar detection
The diagnostic performance of UnipV in identifying any-scar (1–100% scar extent) and seg-
ments with>25%, >50%, and>75% scar extent in the overall population is shown in Table 3
and Fig 2B. UnipV predicted the presence of any-scar moderately for the endocardium
(AUC = 0.68) and poor for the epicardium (AUC = 0.56). Optimal UnipV thresholds in dis-
criminating any-scar from non-scar only yielded moderate sensitivity and specificity: 8.3 mV
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(sensitivity 60%, specificity 67%) for endocardial and 7.6 mV (sensitivity 57%, specificity 52%)
for epicardial measurements. Endocardial UnipV were moderate predictors for segments with
>25% (AUC = 0.72) and>50% (AUC = 0.73) scar extent and fair predictors for segments
with>75% scar (AUC = 0.76), while epicardial UnipV were poor predictors for all severities
of scar (AUC range: 0.47–0.52).
The diagnostic performance of endocardial UnipV in only detecting >75% scar was addi-
tionally evaluated in individual patients. Sixteen out of 33 (48%) endocardial mapped patients
had electrograms recorded both in >75% scar and in75% scar and were further analyzed,
yielding a mean AUC of 0.66±0.19 (AUC range: 0.23–0.96). From these patients, 6/16 (38%)
had an AUC <0.60, indicating poor performance.
Table 1. Patient characteristics.
Endocardial mapping (Group 1) Epicardial mapping (Group 2)
Demographics
Patient number 33 27
Age (years) 69.2±11.1 68.5±9.5
Male 24(73) 20(74)
BMI (kg/m2) 28.2±3.6 27.2±4.2
Ischemic cardiomyopathy 19(58) 19(70)
Non-ischemic cardiomyopathy 14(42) 8(30)
NYHA (I/II/III) 2(6)/14(42)/17(52) 0(0)/18(67)/9(33)
Biological therapy 8 (24%) 0 (0%)
CRT 25 (76%) 27 (100%)
CMR LV function
LV mass (g) 159±39 156±46
Scar present 22(67) 19(70)
Scar (% LV mass) 19±20 11±11
EF (%) 27±8 24±7
EDV (ml) 270±89 291±87
ESV (ml) 199±78 223±74
ECG characteristics
Sinus rhythm 30(91) 26(96)
Atrial fibrillation 3(9) 1(4)
QRS duration (ms) 153±27 153±22
LBBB 21(62) 20(74)
IVCD 5(15) 7(26)
Medication
Antiplatelet 28(82) 15(56)
Coumarins 11(32) 19(70)
Beta-blockers 33(97) 26(96)
Calcium antagonists 2(6) 4(15)
Ace-inhibitor/ARB 30(88) 24(89)
Nitrates 4(12) 18(67)
Diuretics 26(77) 21(78)
Statin 20(59) 19(70)
Values are mean±SD or n(%). ACE = angiotensin-converting-enzyme, ARB = angiotensin-II-receptor-blocker, BMI = body-mass-index, CMR = cardiac
magnetic resonance, CRT = cardiac resynchronization therapy, EDV = end-diastolic volume, ESV = end-systolic volume, IVCD = interventricular
conduction disturbance, LBBB = left bundle branch block, LV = left ventricular, LVEF = LV ejection fraction, NYHA = New York Heart Association.
https://doi.org/10.1371/journal.pone.0180637.t001
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Discussion
In the present study UnipV from either endocardial measurements or epicardial measure-
ments were compared with DE-CMR defined scar in two large cohorts of heterogeneous HF
patients, clinically representative for the patients undergoing EAM investigations. The main
findings of this study are as follow: (1) UnipV in any-scar are moderately lower than in non-
scar, but large overlap exists, particularly for epicardial measurements; (2) UnipV in any-scar
were not significantly lower than non-scar in the majority of patients; (3) A large inter-patient
variability in non-scar UnipV exists; (4) UnipV are inversely correlated with scar extent, but
this was only moderate for endocardial and poor for epicardial measurements; and finally (5)
only scar segments with >75% can be properly identified (AUC = 0.76) by endocardial
UnipV.
Voltage amplitudes and scar in pre-clinical studies
Our results show a large overlap between UnipV from non-scar and any-scar segments. Mod-
erate concordance between low UnipV and scar on DE-CMR has also been previously
reported. In a recent study, infarct size as defined by endocardial UnipV of<5 mV was com-
pared with scar on DE-CMR in 60 infarcted porcine hearts. [2] Despite the use of a large num-
ber of study subjects where complete myocardial scars were employed under controllable
circumstances, only a moderate correlation (R = 0.504) between UnipV and scar extent was
reported.
The overlap in UnipV from non-scar and scar found in our study was larger in epicardial
measurements compared to endocardial measurements, and particularly apparent in segments
with less than 75% scar, supposedly areas with non-transmural scar. This indicates that UnipV
from epicardial measurements are particularly poor at defining scar, and only segments with
extensive infarction (transmural) can be detected properly by endocardial measurements. The
observation that epicardial measurements are inferior at predicting scar than endocardial mea-
surements is not entirely new. Lower concordance between bipolar voltage amplitudes and
DE-CMR defined scar in epicardial measurements (7/28 maps) compared to endocardial mea-
surements (3/28 maps) has also been reported by Arenal et al. in 31 post-infarct porcine
hearts.[14] Additionally Tung et al. demonstrated in 8 post-infarct porcine hearts that
Table 2. Unipolar voltage amplitude distribution in non-scar and scar.
Substrate Endocardial
(Group 1)
p-value Epicardial
(Group 2)
p-value
Electrogram (n) Median (IQR) Electrogram (n) Median (IQR)
Non-scar
0% 3002 10.3 (7.4–14.2) - 778 7.8 (4.2–12.3) -
Any-scara
1–100% 3541 7.1 (4.6–10.6) <0.001 552 6.7 (3.6–10.5) <0.001
Scar groupsb
1–25% 1535 8.6 (6.0–12.3) <0.001 234 6.1 (2.7–9.8) <0.001
26–50% 675 7.0 (4.7–10.4) <0.001 159 7.4 (4.2–11.2) 0.442
51–75% 501 7.0 (4.3–9.8) <0.001 102 5.8 (3.2–9.9) 0.002
76–100% 830 5.0 (3.0–7.3) <0.001 57 7.9 (6.4–10.3) 1.000
aP-values between non-scar and any-scar are based on linear mixed models.
bP-values for the scar-groups are based on ANOVA tests with post-hoc Bonferroni correction between non-scar and different scar-groups (0% vs. 1–25%
scar, 0% vs. 26–50% scar etc.). UnipV are displayed as median and IQR.
https://doi.org/10.1371/journal.pone.0180637.t002
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epicardial bipolar voltage amplitudes in histological confirmed scar have similar values in fat,
but longer electrogram duration, indicating that fat tissue alone can already result in low
UnipV values. Epicardial fat was predominantly found in the basal portion of the interventric-
ular course of the left anterior descending artery up to the left atrial appendage and the atria-
ventricular groove from the basal portion of the posterior interventricular septum to the basal
lateral wall.[6] The coronary venous tributaries we derived our epicardial electrograms from,
are typically located in correspondence of these anatomical sites. Therefore, the poorer
Fig 2. A. Unipolar voltage (UnipV) distribution grouped according to DE-CMR defined scar extent (red) and compared with non-scar (blue).
Dashed blue lines represent optimal thresholds: 8.3 mV for the endocardial measurements, and 7.6 mV for the epicardial measurements. The
tops and bottoms of each "box" represent the 25th and 75th percentiles of the subgroups, respectively. Distances between the tops and
bottoms of each box represent the interquartile ranges. The horizontal middle line in the box represents the median value. The whiskers
(vertical lines) above and below each box are drawn from the ends of the interquartile ranges to the furthest observations within the whisker
length. B. ROC curves for UnipV in identifying DE-CMR defined segments with any-scar (1–100% scar) and segments with several severities of
scar (>25%, >50%, and >75%). Note that the endocardial measurements are superior in detecting scar, independent of scar burden, although
only segments with >75% scar can be properly detected (AUC 0.76) using endocardial measurements.
https://doi.org/10.1371/journal.pone.0180637.g002
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performance of epicardial electrograms compared to endocardial may be at least partially
explained by the presence of epicardial fat.
Taken collectively, pre-clinical data show a high variability in relation between voltage
amplitudes and scar, despite that they were performed under controllable circumstances and
employed complete infarctions. So even in these controlled conditions the relation between
low voltage amplitude and myocardial scar is not very clear, which makes the findings in our
study in heterogeneous and clinical HF patients with more complicated scar architecture
understandable.
Fig 3. Endocardial and epicardial box-plots of the unipolar voltage (UnipV) distribution per individual patient in non-scar (0%, blue)
and any-scar (1–100%, red). P-values per individual patient are based on Mann-Whitney U tests; a p-value of0.05 is considered as
significant (*), while p-values >0.05 are regarded as not significant (NS). Note that significantly lower UnipV in scar compared to non-scar were
only present in the minority of patients. Patients without scar on delayed enhancement cardiac magnetic resonance imaging (DE-CMR) are
plotted on the right. Dashed blue lines represent optimal voltage thresholds. Note the large variation in voltages from non-scar between
individual patients.
https://doi.org/10.1371/journal.pone.0180637.g003
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Voltage amplitudes and scar in clinical studies
In the present study non-scar UnipV both from endocardial as well as epicardial measure-
ments varied considerably between individuals, even in patients without any scar. In addition,
UnipV in any-scar were not significantly lower compared to non-scar in the majority of
patient, demonstrating again that the use of universal voltage thresholds to detect scar may not
be applicable for a substantial number of patients. Previous clinical studies that investigated
the relation between voltage amplitudes and scar mostly grouped the data, whereby inter-indi-
vidual differences remained unnoticed. A few studies employed endocardial mapping to inves-
tigate the relation between voltage amplitudes and DE-CMR scar. Edocardial UnipV were
compared with scar on DE-CMR in 15 CRT candidates with ischemic cardiomyopathy.[15]
UnipV thresholds could differentiate scar from non-scar with a good AUC. However,
DE-CMR scar was determined using visual analyses and the total number of DE-CMR seg-
ments from subendocardial (n = 49) and transmural scar (n = 15) was small in comparison
with segments from non-scar (n = 211), which may have led to less reliable estimations. In a
study from Condreanu et al., endocardial UnipV were significantly lower in areas of DE-CMR
defined scar compared to non-scar in 10 candidates for VT ablation, but similar to our find-
ings no strong linear correlation between UnipV and scar extent was present.[9] Additionally
in another study from Wijnmalen et al., in 15 candidates for VT ablation, endocardial UnipV
decreased significantly with increasing scar transmurality, but a high overlap between non-
Fig 4. Representative patient (endocardial no.26) from without scar on delayed enhancement cardiac magnetic
resonance imaging (DE-CMR). All unipolar electrograms were in non-scar, but still low unipolar voltage amplitudes (UnipV)
were measured, demonstrating a lack of correlation between normal UnipV and non-scar. EAM = electro-anatomic mapping,
LAO = left anterior oblique, RAO = right anterior oblique.
https://doi.org/10.1371/journal.pone.0180637.g004
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scar and sub-scar groups (with different scar severity) was present. Voltage thresholds were
only able to delineate segments with >75% scar properly.[3] In this context, our finding that
endocardial UnipV only detected segments >75% scar properly, seems reasonable.
In a study from Piers et al. epicardial UnipV were compared to DE-CMR defined scar and
CT defined fat in 10 non-ischemic VT patients. UnipV detected scar properly in areas with
Fig 5. Representative patient (epicardial no.19) with extensive scar on delayed enhancement cardiac magnetic
resonance imaging (DE-CMR). All unipolar electrograms were in extensive scar, but normal unipolar voltage amplitudes
(UnipV) were still present demonstrating a lack of correlation between low UnipV and scar. EAM = electro-anatomic mapping,
LAO = left anterior oblique, RAO = right anterior oblique.
https://doi.org/10.1371/journal.pone.0180637.g005
Table 3. Unipolar voltage amplitudes in detecting DE-CMR defined scar.
Substrate Endocardial UnipV
(Group 1)
p-valuea Epicardial UnipV
(Group 2)
p-value a
AUC (CI) AUC (CI)
Any-scar
1–100% scar 0.68 (0.67–0.70) <0.001 0.56 (0.53–0.59) <0.001
Scar extent higher than
>25% 0.72 (0.71–0.74) <0.001 0.52 (0.48–0.55) 0.424
>50% 0.73 (0.72–0.75) <0.001 0.54(0.50–0.58) 0.107
>75% 0.76 (0.74–0.78) <0.001 0.47 (0.40–0.53) 0.399
aP-values are based on the non-parametric assumption (H0: true area = 0.50). AUC = Area under the curve, CI = confidence interval, UnipV = unipolar
voltage.
https://doi.org/10.1371/journal.pone.0180637.t003
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<2.8 mm fat, but not in areas with2.8 mm fat.[10] These data support the importance of
epicardial fat in modifying voltage amplitudes and may well explain the lack of correlation
between epicardial UnipV and scar observed by us.
Taken together, results from previous clinical studies in VT and HF patients confirm the
poor correlation between UnipV and scar extent and demonstrate that UnipV may only work
for the detecting segments with high scar transmurality. The similarities in results between our
cohort and the previous studies are important, because most of the previous studies investi-
gated VT patients, who may have less severe HF than our population. Therefore, the poor cor-
relation between scar and UnipV appears a general property, not limited to a specific patient
population.
Factors affecting voltage amplitudes
The imperfect relation between low voltage amplitude and scar may be understood by multiple
factors influencing the electrogram including inter-individual differences, electrode size, cath-
eter orientation, fiber orientation, contact force, fat tissue, LV wall thickness, and activation
wavefront.[10, 16–18] Obviously, the electrode size within each study (endocardial or epicar-
dial EAM) was kept constant for all locations. Epicardial UnipV were generally lower com-
pared to the endocardial measurements, possibly because of difference in EAM systems,
electrode size or shape, and the presence of epicardial fat. The large inter-patient differences
can however only be explained by differences in tissue properties, because it is hard to imagine
that contact force is consistently lower in one patient than another. Site-to site variability in
contact force and electrode orientation may furthermore explain intra-patient differences.
Fiber orientation and activation wavefront can cause differences in voltage amplitudes, since
these differences may occur locally and between patients. The role of epicardial fat seems sup-
ported by the weaker correlation between UnipV and scar in the epicardial measurements
compared to the endocardial measurements. Besides epicardial fat, other possible mechanisms
might have contributed to this observation. First, a typical non-transmural star is often located
at the endocardium, and it is likely that epicardial measurements are less influenced by endo-
cardial scar due to the interfering myocardium, than endocardial measurements. However, the
larger field of view for unipolar recordings compared to bipolar recordings should (at least
partially) compensate for this effect.[19] Second, epicardial measurements were limited to the
anatomy of the coronary veins, during which the catheter was mostly oriented parallel to the
long axis of the heart along the anatomy of the coronary tributaries and are therefore more
prone to poor contact force, due to limited freedom of catheter movement compared to endo-
cardial measurements. However, all the above elaborated factors are unlikely to affect endocar-
dial measurements, and cannot fully explain the moderate correlation between endocardial
UnipV and scar.
Clinical implications
To date, the majority of EAM vendors incorporate the option to set voltage thresholds for scar
delineation. Yet, evidence that these thresholds delineate scar accurately is scarce. In our large
population, normal median UnipV already ranged tremendously, which argues against the use
of universal voltage thresholds. This idea is supported by the large inter-individual variation in
bipolar voltage amplitudes reported by Cassidy et al.[17] In case of regional scar, regional differ-
ences in amplitudes may be helpful, but only to predict (almost) transmural scars. Therefore,
associating low voltage amplitudes with scar should be done with caution and may only work in
tissue with extensive scarring. Cautiousness is also in place in the detection of arrhythmogenic
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substrate and critical sites of VT ablation, as these procedures also could rely on low voltage
areas.
Limitations
In our DE-CMR analyses approach, a segment was categorized as any-scar when 1–100%
delayed enhancement was present. While this approach may have led to smaller UnipV differ-
ences between non-scar and any-scar, the weak correlation found between UnipV and scar
extent is not affected by thresholds used for scar detection. Additionally, sub-analyses for scar
groups with different severities of scar were carried out.
EAMs were acquired with a NOGA catheter for the endocardial measurements and a guide-
wire in the coronary veins for the epicardial measurements. There are other techniques to per-
form EAM, but the fact that two different techniques show similar results suggests that the
present results can be largely extrapolated to other EAM systems. However, UnipV thresholds
and accuracy values obtained in the present study need to be tested and validated in an inde-
pendent population, using other EAM systems, albeit the measured UnipV should not depend
on the mapping system utilized.
Other electrogram characteristics such as fractionation and long duration could also play a
role in scar detection. Whether these parameters would be superior in identifying scar than
UnipV is left to be investigated.
Conclusion
UnipV in scar defined by DE-CMR are moderately lower than in non-scar, but large overlap
in UnipV between non-scar and scar and high inter-patient variability exists, particularly in
patients undergoing epicardial measurements and segments with lower scar extent. The only
reasonably scar assessment can be expected when using endocardial UnipV measurements for
the detection of segments with>75% scar. Based on the current results, the use of low UnipV
for identification of myocardial scar should be done with caution.
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